US6057287A
(en)
|
1994-01-11 |
2000-05-02 |
Dyax Corp. |
Kallikrein-binding "Kunitz domain" proteins and analogues thereof
|
US20020064546A1
(en)
*
|
1996-09-13 |
2002-05-30 |
J. Milton Harris |
Degradable poly(ethylene glycol) hydrogels with controlled half-life and precursors therefor
|
AU4648697A
(en)
|
1996-09-23 |
1998-04-14 |
Chandrashekar Pathak |
Methods and devices for preparing protein concentrates
|
US8003705B2
(en)
|
1996-09-23 |
2011-08-23 |
Incept Llc |
Biocompatible hydrogels made with small molecule precursors
|
US6258351B1
(en)
*
|
1996-11-06 |
2001-07-10 |
Shearwater Corporation |
Delivery of poly(ethylene glycol)-modified molecules from degradable hydrogels
|
US6448369B1
(en)
|
1997-11-06 |
2002-09-10 |
Shearwater Corporation |
Heterobifunctional poly(ethylene glycol) derivatives and methods for their preparation
|
US7642323B2
(en)
|
1997-11-06 |
2010-01-05 |
Nektar Therapeutics |
Heterobifunctional poly(ethylene glycol) derivatives and methods for their preparation
|
DK1053019T3
(en)
*
|
1998-01-07 |
2004-04-13 |
Debio Rech Pharma Sa |
Degradable heterobifunctional polyethylene glycol acrylates and gels and conjugates derived therefrom
|
US7790192B2
(en)
|
1998-08-14 |
2010-09-07 |
Accessclosure, Inc. |
Apparatus and methods for sealing a vascular puncture
|
GB2341185A
(en)
*
|
1998-09-07 |
2000-03-08 |
Polybiomed Ltd |
Polymerizable material and adhesive sheet material therefrom; dressings, electrodes and transdermal patches
|
WO2000015117A1
(en)
|
1998-09-17 |
2000-03-23 |
Focal, Inc. |
Self-cleaning fluid delivery device for medical applications
|
US6958212B1
(en)
|
1999-02-01 |
2005-10-25 |
Eidgenossische Technische Hochschule Zurich |
Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds
|
MXPA01007777A
(en)
|
1999-02-01 |
2003-10-06 |
Eidgenoess Tech Hochschule |
Biomaterials formed by nucleophilic addition reaction to conjugated unsaturated groups.
|
US7192713B1
(en)
|
1999-05-18 |
2007-03-20 |
President And Fellows Of Harvard College |
Stabilized compounds having secondary structure motifs
|
US6828412B1
(en)
*
|
1999-09-03 |
2004-12-07 |
School Of Pharmacy, University Of London |
Degradable polymers
|
US7037992B2
(en)
*
|
1999-09-29 |
2006-05-02 |
Sri International |
Olefin copolymers containing hydrolytically cleavable linkages and use thereof in degradable products
|
US6288184B1
(en)
*
|
1999-09-29 |
2001-09-11 |
Sri International |
Hydrolytically degradable olefin copolymers
|
NZ518143A
(en)
*
|
1999-10-08 |
2004-04-30 |
Nektar Therapeutics Al Corp |
Heterobifunctional poly(ethylene glycol) derivatives and methods for their preparation
|
WO2001046291A1
(en)
|
1999-12-22 |
2001-06-28 |
Shearwater Corporation |
Sterically hindered derivatives of water soluble polymers
|
US7291673B2
(en)
|
2000-06-02 |
2007-11-06 |
Eidgenossiche Technische Hochschule Zurich |
Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds
|
US7052686B2
(en)
|
2000-09-29 |
2006-05-30 |
Schering Corporation |
Pegylated interleukin-10
|
EP1355965B1
(en)
|
2000-10-19 |
2012-09-19 |
Ecole Polytechnique Fédérale de Lausanne (EPFL) |
Method of synthesizing block copolymers for multifunctional self-assembled systems
|
US7829074B2
(en)
|
2001-10-18 |
2010-11-09 |
Nektar Therapeutics |
Hydroxypatite-targeting poly(ethylene glycol) and related polymers
|
TWI246524B
(en)
|
2001-01-19 |
2006-01-01 |
Shearwater Corp |
Multi-arm block copolymers as drug delivery vehicles
|
US7265186B2
(en)
*
|
2001-01-19 |
2007-09-04 |
Nektar Therapeutics Al, Corporation |
Multi-arm block copolymers as drug delivery vehicles
|
GB0116143D0
(en)
*
|
2001-07-02 |
2001-08-22 |
Amersham Pharm Biotech Uk Ltd |
Chemical capture reagent
|
US7214660B2
(en)
|
2001-10-10 |
2007-05-08 |
Neose Technologies, Inc. |
Erythropoietin: remodeling and glycoconjugation of erythropoietin
|
US7157277B2
(en)
|
2001-11-28 |
2007-01-02 |
Neose Technologies, Inc. |
Factor VIII remodeling and glycoconjugation of Factor VIII
|
US7173003B2
(en)
|
2001-10-10 |
2007-02-06 |
Neose Technologies, Inc. |
Granulocyte colony stimulating factor: remodeling and glycoconjugation of G-CSF
|
US7795210B2
(en)
|
2001-10-10 |
2010-09-14 |
Novo Nordisk A/S |
Protein remodeling methods and proteins/peptides produced by the methods
|
ES2556338T3
(en)
|
2001-10-10 |
2016-01-15 |
Novo Nordisk A/S |
Remodeling and glycoconjugation of peptides
|
AU2004236174B2
(en)
|
2001-10-10 |
2011-06-02 |
Novo Nordisk A/S |
Glycopegylation methods and proteins/peptides produced by the methods
|
EP2305311A3
(en)
|
2001-10-10 |
2011-07-20 |
BioGeneriX AG |
Glycoconjugation of peptides
|
DK1941867T3
(en)
|
2002-06-07 |
2012-01-02 |
Dyax Corp |
Polypeptide with Modified Kunitz Domain
|
US7153829B2
(en)
|
2002-06-07 |
2006-12-26 |
Dyax Corp. |
Kallikrein-inhibitor therapies
|
US7217254B2
(en)
|
2002-09-20 |
2007-05-15 |
Genzyme Corporation |
Multi-pressure biocompatible agent delivery device and method
|
HUE034378T2
(en)
|
2002-10-16 |
2018-02-28 |
Purdue Pharma Lp |
Antibodies that bind cell-associated CA 125/O722P and methods of use thereof
|
US7311926B2
(en)
*
|
2002-12-20 |
2007-12-25 |
Battelle Memorial Institute |
Biocomposite materials and methods for making the same
|
CA2519092C
(en)
|
2003-03-14 |
2014-08-05 |
Neose Technologies, Inc. |
Branched water-soluble polymers and their conjugates
|
US8791070B2
(en)
|
2003-04-09 |
2014-07-29 |
Novo Nordisk A/S |
Glycopegylated factor IX
|
ES2380093T3
(en)
|
2003-05-09 |
2012-05-08 |
Biogenerix Ag |
Compositions and methods for the preparation of human growth hormone glycosylation mutants
|
WO2005012484A2
(en)
|
2003-07-25 |
2005-02-10 |
Neose Technologies, Inc. |
Antibody-toxin conjugates
|
PT1663281E
(en)
*
|
2003-08-29 |
2014-03-17 |
Dyax Corp |
Poly-pegylated protease inhibitors
|
US7786213B2
(en)
*
|
2003-10-15 |
2010-08-31 |
The Regents Of The University Of California |
Biomacromolecule polymer conjugates
|
ES2586387T3
(en)
|
2003-11-05 |
2016-10-14 |
Dana-Farber Cancer Institute, Inc. |
Suitable alpha helical peptides to activate or inhibit cell death
|
US8633157B2
(en)
|
2003-11-24 |
2014-01-21 |
Novo Nordisk A/S |
Glycopegylated erythropoietin
|
US7842661B2
(en)
|
2003-11-24 |
2010-11-30 |
Novo Nordisk A/S |
Glycopegylated erythropoietin formulations
|
US20080305992A1
(en)
|
2003-11-24 |
2008-12-11 |
Neose Technologies, Inc. |
Glycopegylated erythropoietin
|
US20060040856A1
(en)
|
2003-12-03 |
2006-02-23 |
Neose Technologies, Inc. |
Glycopegylated factor IX
|
US7956032B2
(en)
|
2003-12-03 |
2011-06-07 |
Novo Nordisk A/S |
Glycopegylated granulocyte colony stimulating factor
|
WO2005061018A1
(en)
*
|
2003-12-22 |
2005-07-07 |
Regentis Biomaterials Ltd. |
Matrix comprising naturally-occurring protein backbone
|
US7842667B2
(en)
|
2003-12-22 |
2010-11-30 |
Regentis Biomaterials Ltd. |
Matrix composed of a naturally-occurring protein backbone cross linked by a synthetic polymer and methods of generating and using same
|
CN101072789B
(en)
|
2004-01-08 |
2013-05-15 |
生物种属学股份公司 |
O-linked glycosylation of peptides
|
WO2005115477A2
(en)
|
2004-04-13 |
2005-12-08 |
Quintessence Biosciences, Inc. |
Non-natural ribonuclease conjugates as cytotoxic agents
|
US7282584B2
(en)
|
2004-06-16 |
2007-10-16 |
Straumann Holding Ag |
Methylene blue
|
EP1609491B1
(en)
|
2004-06-16 |
2008-02-06 |
Straumann Holding AG |
Barrier membrane
|
EP1625856A1
(en)
*
|
2004-08-13 |
2006-02-15 |
Complex Biosystems GmbH |
Hydrogel polymeric conjugates of a prodrug
|
EP2594291A1
(en)
|
2004-07-05 |
2013-05-22 |
Ascendis Pharma GmbH |
Hydrogel
|
US7968085B2
(en)
|
2004-07-05 |
2011-06-28 |
Ascendis Pharma A/S |
Hydrogel formulations
|
WO2006010143A2
(en)
|
2004-07-13 |
2006-01-26 |
Neose Technologies, Inc. |
Branched peg remodeling and glycosylation of glucagon-like peptide-1 [glp-1]
|
EP1799249A2
(en)
|
2004-09-10 |
2007-06-27 |
Neose Technologies, Inc. |
Glycopegylated interferon alpha
|
US7235530B2
(en)
|
2004-09-27 |
2007-06-26 |
Dyax Corporation |
Kallikrein inhibitors and anti-thrombolytic agents and uses thereof
|
EP1814573B1
(en)
|
2004-10-29 |
2016-03-09 |
ratiopharm GmbH |
Remodeling and glycopegylation of fibroblast growth factor (fgf)
|
NZ556436A
(en)
|
2005-01-10 |
2010-11-26 |
Biogenerix Ag |
Glycopegylated granulocyte colony stimulating factor
|
AU2006213822B2
(en)
|
2005-02-09 |
2011-05-26 |
Covidien Lp |
Synthetic sealants
|
US20060222596A1
(en)
|
2005-04-01 |
2006-10-05 |
Trivascular, Inc. |
Non-degradable, low swelling, water soluble radiopaque hydrogel polymer
|
US7517914B2
(en)
|
2005-04-04 |
2009-04-14 |
Boston Scientificscimed, Inc. |
Controlled degradation materials for therapeutic agent delivery
|
US9187546B2
(en)
|
2005-04-08 |
2015-11-17 |
Novo Nordisk A/S |
Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants
|
JP5216580B2
(en)
|
2005-05-25 |
2013-06-19 |
ノヴォ ノルディスク アー/エス |
Glycopegylated factor IX
|
EP1891141B1
(en)
|
2005-05-31 |
2016-11-16 |
Ecole Polytechnique Fédérale de Lausanne (EPFL) |
Triblock copolymers for cytoplasmic delivery of gene-based drugs
|
WO2007007392A1
(en)
*
|
2005-07-11 |
2007-01-18 |
Wako Pure Chemical Industries, Ltd. |
Novel polymer and method of measuring cholesterol therewith
|
EP1926768B1
(en)
|
2005-07-18 |
2011-09-14 |
Nektar Therapeutics |
Branched functionalized polymers using branched polyol cores
|
GB0515625D0
(en)
*
|
2005-07-29 |
2005-09-07 |
Univ Manchester |
Hydrogel particle
|
US20070105755A1
(en)
|
2005-10-26 |
2007-05-10 |
Neose Technologies, Inc. |
One pot desialylation and glycopegylation of therapeutic peptides
|
JP2007112924A
(en)
*
|
2005-10-21 |
2007-05-10 |
National Institute For Materials Science |
Polymer cross-linking agent and liposome or cell cross-linked product using the cross-linking agent
|
US20090048440A1
(en)
|
2005-11-03 |
2009-02-19 |
Neose Technologies, Inc. |
Nucleotide Sugar Purification Using Membranes
|
EP2023941B1
(en)
|
2006-04-24 |
2016-12-21 |
Incept, LLC |
Protein crosslinkers, crosslinking methods and applications thereof
|
US7872068B2
(en)
|
2006-05-30 |
2011-01-18 |
Incept Llc |
Materials formable in situ within a medical device
|
JP2009541333A
(en)
|
2006-06-23 |
2009-11-26 |
クインテセンス バイオサイエンシーズ インコーポレーティッド |
Modified ribonuclease
|
EP2049151A4
(en)
|
2006-07-17 |
2010-03-24 |
Quintessence Biosciences Inc |
Methods and compositions for the treatment of cancer
|
JP2009544327A
(en)
|
2006-07-21 |
2009-12-17 |
ノヴォ ノルディスク アー/エス |
Glycosylation of peptides with O-linked glycosylation sequences
|
US8268948B2
(en)
*
|
2006-07-21 |
2012-09-18 |
Nektar Therapeutics |
Polymeric reagents comprising a terminal vinylic group and conjugates formed therefrom
|
EP2821078B1
(en)
|
2006-09-28 |
2016-09-21 |
Merck Sharp & Dohme Corp. |
Pegylated il-10 for use in treating lymphoma
|
JP2010505874A
(en)
|
2006-10-03 |
2010-02-25 |
ノヴォ ノルディスク アー/エス |
Purification method for polypeptide conjugates
|
LT2068907T
(en)
|
2006-10-04 |
2018-01-10 |
Novo Nordisk A/S |
Glycerol linked pegylated sugars and glycopeptides
|
US8394483B2
(en)
|
2007-01-24 |
2013-03-12 |
Micron Technology, Inc. |
Two-dimensional arrays of holes with sub-lithographic diameters formed by block copolymer self-assembly
|
ES2558928T3
(en)
|
2007-01-31 |
2016-02-09 |
Dana-Farber Cancer Institute, Inc. |
Stabilized p53 peptides and uses thereof
|
US8083953B2
(en)
|
2007-03-06 |
2011-12-27 |
Micron Technology, Inc. |
Registered structure formation via the application of directed thermal energy to diblock copolymer films
|
US8557128B2
(en)
|
2007-03-22 |
2013-10-15 |
Micron Technology, Inc. |
Sub-10 nm line features via rapid graphoepitaxial self-assembly of amphiphilic monolayers
|
KR101623985B1
(en)
|
2007-03-28 |
2016-05-25 |
프레지던트 앤드 펠로우즈 오브 하바드 칼리지 |
Stitched polypeptides
|
KR20150064246A
(en)
|
2007-04-03 |
2015-06-10 |
바이오제너릭스 게엠베하 |
Methods of treatment using glycopegylated g―csf
|
US8294139B2
(en)
|
2007-06-21 |
2012-10-23 |
Micron Technology, Inc. |
Multilayer antireflection coatings, structures and devices including the same and methods of making the same
|
US7959975B2
(en)
|
2007-04-18 |
2011-06-14 |
Micron Technology, Inc. |
Methods of patterning a substrate
|
US8097175B2
(en)
|
2008-10-28 |
2012-01-17 |
Micron Technology, Inc. |
Method for selectively permeating a self-assembled block copolymer, method for forming metal oxide structures, method for forming a metal oxide pattern, and method for patterning a semiconductor structure
|
US8372295B2
(en)
|
2007-04-20 |
2013-02-12 |
Micron Technology, Inc. |
Extensions of self-assembled structures to increased dimensions via a “bootstrap” self-templating method
|
US20080287633A1
(en)
*
|
2007-05-18 |
2008-11-20 |
Drumheller Paul D |
Hydrogel Materials
|
JP5876649B2
(en)
|
2007-06-12 |
2016-03-02 |
ラツィオファルム ゲーエムベーハーratiopharm GmbH |
Improved process for producing nucleotide sugars
|
US8404124B2
(en)
*
|
2007-06-12 |
2013-03-26 |
Micron Technology, Inc. |
Alternating self-assembling morphologies of diblock copolymers controlled by variations in surfaces
|
US8080615B2
(en)
|
2007-06-19 |
2011-12-20 |
Micron Technology, Inc. |
Crosslinkable graft polymer non-preferentially wetted by polystyrene and polyethylene oxide
|
WO2009026334A2
(en)
*
|
2007-08-21 |
2009-02-26 |
Genzyme Corporation |
Treatment with kallikrein inhibitors
|
US8207112B2
(en)
|
2007-08-29 |
2012-06-26 |
Biogenerix Ag |
Liquid formulation of G-CSF conjugate
|
JP2010540681A
(en)
*
|
2007-10-08 |
2010-12-24 |
クインテッセンス バイオサイエンシズ,インコーポレーテッド |
Compositions and methods for ribonuclease based therapy
|
US8999492B2
(en)
|
2008-02-05 |
2015-04-07 |
Micron Technology, Inc. |
Method to produce nanometer-sized features with directed assembly of block copolymers
|
EP2247645B1
(en)
*
|
2008-02-13 |
2017-12-06 |
Hyperbranch Medical Technology, Inc. |
Crosslinked polyalkyleneimine hydrogels with tunable degradation rates
|
US8101261B2
(en)
|
2008-02-13 |
2012-01-24 |
Micron Technology, Inc. |
One-dimensional arrays of block copolymer cylinders and applications thereof
|
JP5150297B2
(en)
*
|
2008-02-14 |
2013-02-20 |
ネクター セラピューティックス エイエル,コーポレイション |
Heterobifunctional polyethylene glycol derivatives and methods for their preparation
|
CN103497246B
(en)
|
2008-02-27 |
2016-08-10 |
诺沃—诺迪斯克有限公司 |
The Factor VlII molecule puted together
|
US8426313B2
(en)
|
2008-03-21 |
2013-04-23 |
Micron Technology, Inc. |
Thermal anneal of block copolymer films with top interface constrained to wet both blocks with equal preference
|
US8425982B2
(en)
|
2008-03-21 |
2013-04-23 |
Micron Technology, Inc. |
Methods of improving long range order in self-assembly of block copolymer films with ionic liquids
|
US8114300B2
(en)
|
2008-04-21 |
2012-02-14 |
Micron Technology, Inc. |
Multi-layer method for formation of registered arrays of cylindrical pores in polymer films
|
US8114301B2
(en)
|
2008-05-02 |
2012-02-14 |
Micron Technology, Inc. |
Graphoepitaxial self-assembly of arrays of downward facing half-cylinders
|
WO2010014258A2
(en)
*
|
2008-08-01 |
2010-02-04 |
Nektar Therapeutics Al, Corporation |
Conjugates having a releasable linkage
|
JP5435536B2
(en)
*
|
2008-09-04 |
2014-03-05 |
学校法人神奈川大学 |
Photodegradable block copolymer
|
JP2012503025A
(en)
|
2008-09-22 |
2012-02-02 |
エルロン・セラピューティクス・インコーポレイテッド |
Method for preparing a purified polypeptide composition
|
JP2012504423A
(en)
|
2008-10-01 |
2012-02-23 |
クインテッセンス バイオサイエンシズ,インコーポレーテッド |
Therapeutic ribonuclease
|
US9271929B2
(en)
|
2008-11-25 |
2016-03-01 |
École Polytechnique Fédérale De Lausanne (Epfl) |
Block copolymers and uses thereof
|
WO2010067378A2
(en)
|
2008-12-08 |
2010-06-17 |
Reliance Life Sciences Pvt. Ltd. |
Hydrogel composition
|
AU2010203712A1
(en)
|
2009-01-06 |
2010-07-15 |
Dyax Corp. |
Treatment of mucositis with kallikrein inhibitors
|
BRPI1006139A2
(en)
|
2009-01-14 |
2017-05-30 |
Aileron Therapeutics Inc |
peptidomimetic macrocycles
|
US8409606B2
(en)
|
2009-02-12 |
2013-04-02 |
Incept, Llc |
Drug delivery through hydrogel plugs
|
JP5684239B2
(en)
|
2009-05-04 |
2015-03-11 |
インセプト・リミテッド・ライアビリティ・カンパニーIncept Llc |
Biomaterial for track and puncture closure
|
RS56496B1
(en)
|
2009-06-09 |
2018-01-31 |
Prolong Pharmaceuticals Llc |
Hemoglobin compositions
|
ES2636741T3
(en)
|
2009-07-31 |
2017-10-09 |
Sanofi-Aventis Deutschland Gmbh |
Long-acting insulin composition
|
WO2011012718A1
(en)
|
2009-07-31 |
2011-02-03 |
Ascendis Pharma As |
Prodrugs comprising an insulin linker conjugate
|
JP4704506B2
(en)
*
|
2009-08-11 |
2011-06-15 |
財団法人川村理化学研究所 |
Organic-inorganic composite hydrogel and method for producing the same
|
CA2774973A1
(en)
|
2009-09-22 |
2011-03-31 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
US20110081398A1
(en)
*
|
2009-10-01 |
2011-04-07 |
Tyco Healthcare Group Lp |
Multi-mechanism surgical compositions
|
US20110081701A1
(en)
*
|
2009-10-02 |
2011-04-07 |
Timothy Sargeant |
Surgical compositions
|
US8968785B2
(en)
*
|
2009-10-02 |
2015-03-03 |
Covidien Lp |
Surgical compositions
|
JP5552310B2
(en)
|
2009-12-24 |
2014-07-16 |
日清紡ホールディングス株式会社 |
Resin crosslinking agent
|
WO2011085103A2
(en)
|
2010-01-06 |
2011-07-14 |
Dyax Corp. |
Plasma kallikrein binding proteins
|
US8524215B2
(en)
*
|
2010-08-02 |
2013-09-03 |
Janssen Biotech, Inc. |
Absorbable PEG-based hydrogels
|
DK2603600T3
(en)
|
2010-08-13 |
2019-03-04 |
Aileron Therapeutics Inc |
PEPTIDOMIMETIC MACROCYCLES
|
US8304493B2
(en)
|
2010-08-20 |
2012-11-06 |
Micron Technology, Inc. |
Methods of forming block copolymers
|
EP2438930A1
(en)
|
2010-09-17 |
2012-04-11 |
Sanofi-Aventis Deutschland GmbH |
Prodrugs comprising an exendin linker conjugate
|
CA2817568A1
(en)
|
2010-11-12 |
2012-05-18 |
The Salk Institute For Biological Studies Intellectual Property And Tech Nology Transfer |
Cancer therapies and diagnostics
|
JP2014506257A
(en)
|
2011-01-06 |
2014-03-13 |
ダイアックス コーポレーション |
Plasma kallikrein binding protein
|
US9096684B2
(en)
|
2011-10-18 |
2015-08-04 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
US8900963B2
(en)
|
2011-11-02 |
2014-12-02 |
Micron Technology, Inc. |
Methods of forming semiconductor device structures, and related structures
|
EP2858661B1
(en)
|
2011-12-29 |
2020-04-22 |
Dana-Farber Cancer Institute, Inc. |
Stabilized antiviral fusion helices
|
AU2013221432B2
(en)
|
2012-02-15 |
2018-01-18 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
WO2013123267A1
(en)
|
2012-02-15 |
2013-08-22 |
Aileron Therapeutics, Inc. |
Triazole-crosslinked and thioether-crosslinked peptidomimetic macrocycles
|
JP5953459B2
(en)
*
|
2012-03-27 |
2016-07-20 |
ネクター セラピューティクス |
Heterobifunctional polyethylene glycol derivatives and methods for their preparation
|
CA3113959A1
(en)
|
2012-09-26 |
2014-04-03 |
President And Fellows Of Harvard College |
Proline-locked stapled peptides and uses thereof
|
US9087699B2
(en)
|
2012-10-05 |
2015-07-21 |
Micron Technology, Inc. |
Methods of forming an array of openings in a substrate, and related methods of forming a semiconductor device structure
|
MX2015005244A
(en)
|
2012-11-01 |
2015-07-14 |
Aileron Therapeutics Inc |
Disubstituted amino acids and methods of preparation and use thereof.
|
EP2991665A4
(en)
|
2013-03-13 |
2016-11-09 |
Harvard College |
Stapled and stitched polypeptides and uses thereof
|
US10258698B2
(en)
|
2013-03-14 |
2019-04-16 |
Modernatx, Inc. |
Formulation and delivery of modified nucleoside, nucleotide, and nucleic acid compositions
|
CA2906775A1
(en)
|
2013-03-15 |
2014-09-18 |
Dana-Farber Cancer Institute, Inc. |
Bh4 stabilized peptides and uses thereof
|
CA2906740A1
(en)
|
2013-03-15 |
2014-09-18 |
Dana-Farber Cancer Institute, Inc. |
Stabilized sos1 peptides
|
US10308926B2
(en)
|
2013-03-15 |
2019-06-04 |
Dana-Farber Cancer Institute, Inc. |
Stablized EZH2 peptides
|
CN106913865A
(en)
|
2013-04-18 |
2017-07-04 |
阿尔莫生物科技股份有限公司 |
The method that disease and illness are treated using interleukin 10
|
US9229328B2
(en)
|
2013-05-02 |
2016-01-05 |
Micron Technology, Inc. |
Methods of forming semiconductor device structures, and related semiconductor device structures
|
KR20160019547A
(en)
|
2013-06-14 |
2016-02-19 |
프레지던트 앤드 펠로우즈 오브 하바드 칼리지 |
Stabilized polypeptide insulin receptor modulators
|
ES2688206T3
(en)
|
2013-06-17 |
2018-10-31 |
Armo Biosciences, Inc. |
Procedure for assessing protein identity and stability
|
WO2015013510A1
(en)
|
2013-07-25 |
2015-01-29 |
Ecole Polytechnique Federale De Lausanne Epfl |
High aspect ratio nanofibril materials
|
WO2015034925A1
(en)
|
2013-09-03 |
2015-03-12 |
Moderna Therapeutics, Inc. |
Circular polynucleotides
|
EP3041934A1
(en)
|
2013-09-03 |
2016-07-13 |
Moderna Therapeutics, Inc. |
Chimeric polynucleotides
|
US9177795B2
(en)
|
2013-09-27 |
2015-11-03 |
Micron Technology, Inc. |
Methods of forming nanostructures including metal oxides
|
AU2014346537A1
(en)
|
2013-11-11 |
2016-05-19 |
Armo Biosciences, Inc. |
Methods of using interleukin-10 for treating diseases and disorders
|
AU2015235967B2
(en)
|
2014-03-27 |
2020-10-22 |
Takeda Pharmaceutical Company Limited |
Compositions and methods for treatment of diabetic macular edema
|
CA2948864C
(en)
|
2014-05-14 |
2023-10-17 |
Karl E. Griswold |
Deimmunized lysostaphin and methods of use
|
JP6759109B2
(en)
|
2014-05-21 |
2020-09-23 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
RAS inhibitory peptides and their use
|
US10293043B2
(en)
|
2014-06-02 |
2019-05-21 |
Armo Biosciences, Inc. |
Methods of lowering serum cholesterol
|
MX2017003819A
(en)
|
2014-09-24 |
2017-06-15 |
Aileron Therapeutics Inc |
Peptidomimetic macrocycles and formulations thereof.
|
WO2016049359A1
(en)
|
2014-09-24 |
2016-03-31 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles and uses thereof
|
KR20170084033A
(en)
|
2014-10-22 |
2017-07-19 |
아르모 바이오사이언시스 인코포레이티드 |
Methods of using interleukin-10 for treating diseases and disorders
|
WO2016126615A1
(en)
|
2015-02-03 |
2016-08-11 |
Armo Biosciences, Inc. |
Methods of using interleukin-10 for treating diseases and disorders
|
WO2016149613A2
(en)
|
2015-03-18 |
2016-09-22 |
Massachusetts Institute Of Technology |
Selective mcl-1 binding peptides
|
WO2016154058A1
(en)
|
2015-03-20 |
2016-09-29 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles and uses thereof
|
CA2986755A1
(en)
|
2015-05-28 |
2016-12-01 |
Armo Biosciences, Inc. |
Pegylated interleukin-10 for use in treating cancer
|
US10059741B2
(en)
|
2015-07-01 |
2018-08-28 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
AU2016287754B2
(en)
|
2015-07-02 |
2021-02-25 |
Dana-Farber Cancer Institute, Inc. |
Stabilized anti-microbial peptides
|
MX2018002298A
(en)
|
2015-08-25 |
2018-07-06 |
Armo Biosciences Inc |
Methods of using interleukin-10 for treating diseases and disorders.
|
EP3341008A4
(en)
|
2015-08-28 |
2019-05-15 |
Dana-Farber Cancer Institute, Inc. |
Peptides binding to bfl-1
|
CN108368161A
(en)
|
2015-09-10 |
2018-08-03 |
艾瑞朗医疗公司 |
Peptidomimetic macrocyclic compound as MCL-1 conditioning agents
|
JP6184462B2
(en)
*
|
2015-10-28 |
2017-08-23 |
ウェルズ ファーゴ バンク ナショナル アソシエイション |
Heterobifunctional polyethylene glycol derivatives and methods for their preparation
|
US11286307B2
(en)
|
2015-12-11 |
2022-03-29 |
Takeda Pharmaceutical Company Limited |
Plasma kallikrein inhibitors and uses thereof for treating hereditary angioedema attack
|
US20170247423A1
(en)
|
2016-02-29 |
2017-08-31 |
Dana-Farber Cancer Institute, Inc. |
Stapled intracellular-targeting antimicrobial peptides to treat infection
|
WO2018017922A2
(en)
|
2016-07-22 |
2018-01-25 |
Massachusetts Institute Of Technology |
Selective bfl-1 peptides
|
EP3503924B1
(en)
|
2016-08-26 |
2022-12-14 |
Dana-Farber Cancer Institute, Inc. |
Bcl-w polypeptides and mimetics for treating or preventing chemotherapy-induced peripheral neuropathy and hearing loss
|
WO2018170299A1
(en)
|
2017-03-15 |
2018-09-20 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Inhibitors of prokaryotic gene transcription and uses thereof
|
JP6361083B2
(en)
*
|
2017-06-27 |
2018-07-25 |
ウェルズ ファーゴ バンク ナショナル アソシエイション |
Heterobifunctional polyethylene glycol derivatives and methods for their preparation
|
JP7305614B2
(en)
|
2017-07-19 |
2023-07-10 |
デイナ ファーバー キャンサー インスティチュート,インコーポレイテッド |
Stabilized antimicrobial peptides for the treatment of antibiotic-resistant bacterial infections
|
US11847932B2
(en)
|
2017-09-07 |
2023-12-19 |
Intuitive Surgical Operations, Inc. |
Modified animal organs for use in surgical simulators
|
EP3737404A1
(en)
|
2017-12-15 |
2020-11-18 |
Dana Farber Cancer Institute, Inc. |
Selective targeting of apoptosis proteins by structurally-stabilized and/or cysteine-reactive noxa peptides
|
EP3724216A1
(en)
|
2017-12-15 |
2020-10-21 |
Dana Farber Cancer Institute, Inc. |
Stabilized peptide-mediated targeted protein degradation
|
EP3749678A1
(en)
|
2018-02-07 |
2020-12-16 |
Dana Farber Cancer Institute, Inc. |
Cell-permeable stapled peptide modules for cellular delivery
|
EP3765852A1
(en)
|
2018-03-14 |
2021-01-20 |
Dana Farber Cancer Institute, Inc. |
Stabilized peptides for biomarker detection
|
JP6500318B2
(en)
*
|
2018-04-04 |
2019-04-17 |
ウェルズ ファーゴ バンク ナショナル アソシエイション |
Heterobifunctional polyethylene glycol derivative and method for preparing the same
|
WO2020060975A1
(en)
|
2018-09-17 |
2020-03-26 |
Massachusetts Institute Of Technology |
Peptides selective for bcl-2 family proteins
|
EP3962933A1
(en)
|
2019-04-18 |
2022-03-09 |
Dana-Farber Cancer Institute, Inc. |
Selective targeting of ubiquitin- and ubiquitin-like e1-activating enzymes by structurally-stabilized peptides
|
CN110759824A
(en)
*
|
2019-09-30 |
2020-02-07 |
兰州交通大学 |
Novel method for synthesizing allyl fatty alcohol polyoxyethylene ether carboxylic acid (APEA-3)
|
CN110668933A
(en)
*
|
2019-09-30 |
2020-01-10 |
兰州交通大学 |
Novel method for synthesizing allyl fatty alcohol polyoxyethylene ether carboxylic acid (APEA-7)
|
EP4077361A1
(en)
|
2019-12-16 |
2022-10-26 |
Dana-Farber Cancer Institute, Inc. |
Structurally-stabilized oncolytic peptides and uses thereof
|
AU2020408070A1
(en)
|
2019-12-20 |
2022-06-09 |
Dana-Farber Cancer Institute, Inc. |
Structurally-stabilized glucagon-like peptide 1 peptides and uses thereof
|
EP4114431A2
(en)
|
2020-03-04 |
2023-01-11 |
Dana-Farber Cancer Institute, Inc. |
Antiviral structurally-stabilized sars-cov-2 peptides and uses thereof
|
AU2021258205A1
(en)
|
2020-04-22 |
2022-10-13 |
Dana-Farber Cancer Institute, Inc. |
Antiviral structurally-stabilized ACE2 helix 1 peptides and uses thereof
|
CA3179873A1
(en)
|
2020-04-27 |
2021-11-04 |
Dana-Farber Cancer Institute, Inc. |
Structurally-stabilized and hdmx-selective p53 peptides and uses thereof
|
US20230330238A1
(en)
|
2020-10-14 |
2023-10-19 |
Dana-Farber Cancer Institute, Inc. |
Chimeric conjugates for degradation of viral and host proteins and methods of use
|
EP4240395A1
(en)
|
2020-11-05 |
2023-09-13 |
Dana-Farber Cancer Institute, Inc. |
Antiviral structurally-stabilized ebolavirus peptides and uses thereof
|
IL311151A
(en)
|
2021-09-08 |
2024-04-01 |
Dana Farber Cancer Inst Inc |
Antiviral structurally-stapled sars-cov-2 peptide- cholesterol conjugates and uses thereof
|
WO2023215784A1
(en)
|
2022-05-04 |
2023-11-09 |
Dana-Farber Cancer Institute, Inc. |
Ebolavirus surface glycoprotein peptides, conjugates, and uses thereof
|